BioAsia 2014: GSK's emerging markets balance and why Seretide generics are no big deal | PharmaBoardroom
written on 24.02.2014
Tags:
,

BioAsia 2014: GSK's emerging markets balance and why Seretide generics are no big deal

TAGS: ,

GSK's senior vice-president and area head (emerging markets and Asia Pacific), Rogerio Ribeiro, explained that the company has a long-term view on emerging markets and while there is currently some volatility in Argentina, Venezuela and Turkey, markets…

Latest Report